Literature DB >> 29330249

Is It Idiopathic Pulmonary Fibrosis or Not?

Mary Salvatore1, Genta Ishikawa2, Maria Padilla2.   

Abstract

Pulmonary fibrosis is not uncommon. Usual interstitial pneumonitis (UIP)/idiopathic pulmonary fibrosis (IPF) is the most common of the idiopathic pulmonary fibrotic diseases and has the worst prognosis with a mean life expectancy of 3.8 years. The American Thoracic Society has provided guidelines for the accurate diagnosis of IPF.In 2014, 2 antifibrotic medications were approved in the United States that target the multiple fibrotic pathways of UIP, which increased the need for early and accurate diagnosis of IPF. The early and correct diagnosis is hampered by mimickers that include nonspecific interstitial pneumonitis, chronic hypersensitivity pneumonitis, and fibrotic sarcoidosis. Careful history taking, serologic testing, and Computer Tomography (CT) inspection can frequently make the correct diagnosis without need of invasive procedure. The purpose of this article is to share the most important aspects of the clinical and radiology presentation of IPF and its mimickers to enhance primary care clinician's ability to correctly and noninvasively diagnose UIP/IPF. © Copyright 2018 by the American Board of Family Medicine.

Entities:  

Keywords:  Idiopathic Pulmonary Fibrosis; Primary Health Care; Sarcoidosis

Mesh:

Year:  2018        PMID: 29330249     DOI: 10.3122/jabfm.2018.01.170288

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  6 in total

1.  Proteomic Analysis Reveals Differential Expression Profiles in Idiopathic Pulmonary Fibrosis Cell Lines.

Authors:  Juan Manuel Velázquez-Enríquez; Alma Aurora Ramírez-Hernández; Luis Manuel Sánchez Navarro; Itayetzi Reyes-Avendaño; Karina González-García; Cristian Jiménez-Martínez; Luis Castro-Sánchez; Xariss Miryam Sánchez-Chino; Verónica Rocío Vásquez-Garzón; Rafael Baltiérrez-Hoyos
Journal:  Int J Mol Sci       Date:  2022-05-01       Impact factor: 6.208

2.  Idiopathic pulmonary fibrosis: Educational needs of health-care providers, patients, and caregivers.

Authors:  Deepa Ramadurai; Stephanie Corder; Tara Churney; Bridget Graney; Andrea Harshman; Sarah Meadows; Jeffrey J Swigris
Journal:  Chron Respir Dis       Date:  2019 Jan-Dec       Impact factor: 2.444

3.  Fellowship Education in Interstitial Lung Disease. A National Survey of Program Directors and Trainees.

Authors:  Jake G Natalini; Stacey M Kassutto; Tristan J Huie; Maryl E Kreider
Journal:  ATS Sch       Date:  2020-08-13

4.  Discrimination between NSIP- and IPF-Derived Fibroblasts Based on Multi-Parameter Characterization of Their Growth, Morphology and Physic-Chemical Properties.

Authors:  Barbara Orzechowska; Kamil Awsiuk; Dawid Wnuk; Joanna Pabijan; Tomasz Stachura; Jerzy Soja; Krzysztof Sładek; Joanna Raczkowska
Journal:  Int J Mol Sci       Date:  2022-02-15       Impact factor: 5.923

5.  Idiopathic Pulmonary Fibrosis: A Case of Mistaken Identity.

Authors:  Jeffrey A Miskoff; Moiuz Chaudhri
Journal:  Cureus       Date:  2019-11-15

6.  Hypercalciuria in Sarcoidosis: A Specific Biomarker With Clinical Utility.

Authors:  Paolo Cameli; Carla Caffarelli; Rosa Metella Refini; Laura Bergantini; Miriana d'Alessandro; Martina Armati; Maria Dea Tomai Pitinca; Piersante Sestini; Stefano Gonnelli; Elena Bargagli
Journal:  Front Med (Lausanne)       Date:  2020-10-29
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.